CE Markings

EU: CE marked for the treatment of Major Depressive Disorder

MagVenture TMS Therapy® is CE marked for the “Treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode”.

Clinical benefit: In individuals who respond to treatment for Major Depressive Disorder and who have symptoms of comorbid anxiety, the clinical benefit may also include improvement of anxiety symptoms.

EU: CE marked for addiction

MagVenture TMS Therapy is indicated for the treatment of Psychoactive Substance Use Disorder (PSUD) caused by substances with a stimulating effect on brain function in adult patients.

EU: CE marked for adjunctive treatment of OCD

MagVenture TMS Therapy® is CE marked “as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

EU: CE marked for diagnostic use

The MagPro® is intended as an electrophysiological tool to assess diagnosis and to monitor diseases of the central and peripheral nervous system, based on the use of Motor Evoked Potential (MEP).